Similarly, Chen et al. demonstrated the presence of PD-L1 on melanoma derived exosomes (a type of EV) and reported that higher levels of circulating exosomal PD-L1 negatively correlated to a poor clinical outcome after ICI therapy [125]. The gene discussed is CD274; the disease is melanoma.